文献速递食管胃疾病与幽门螺杆菌消化内镜消化道肿瘤与早癌

胶囊海绵TFF3检测对GERD患者Barrett食管的诊断准确性:系统综述与荟萃分析

Diagnostic Accuracy of a Capsule Sponge Trefoil Factor 3 Test for Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Gastroenterol · 2026-08-28

该系统综述与荟萃分析纳入6项研究共1454例有反流症状且无BE病史的成人,评估胶囊海绵联合三叶因子3(TFF3)检测Barrett食管的筛查性能。汇总敏感度为0.87(95%CI: 0.80-0.94),特异度为0.88(95%CI: 0.80-0.95),20%患病率下阴性预测值为0.96(95%CI: 0.95-0.98),诊断比值比为47.82(95%CI: 44.99-50.83)。吸烟和抑酸剂使用与特异度升高相关。

要点

  • 胶囊海绵TFF3检测对BE的汇总敏感度0.87、特异度0.88。
  • 20%患病率下阴性预测值达0.96,适合作为微创筛查工具。
  • 吸烟和抑酸剂使用与特异度升高相关,或可减少不必要内镜。

核心结论

  • 胶囊海绵TFF3检测是BE风险患者有效的微创筛查工具。
  • 吸烟者中特异度升高可能有助于减少该高风险人群的不必要内镜。

研究设计与样本

  • 系统综述与荟萃分析,方案注册于PROSPERO(CRD420250652091)。
  • 纳入6项研究共1454例有反流症状且无BE病史的成人,均报告胶囊海绵TFF3与内镜评估结果。
  • 系统检索截至2025年8月29日,两名评价者独立筛选与提取数据,采用QUADAS-2评估偏倚风险。

主要发现

  • BE汇总敏感度为0.87(95%CI: 0.80-0.94)。
  • 汇总特异度为0.88(95%CI: 0.80-0.95)。
  • 20%患病率下阴性预测值为0.96(95%CI: 0.95-0.98)。
  • 诊断比值比为47.82(95%CI: 44.99-50.83)。
  • 吸烟和抑酸剂使用与特异度升高相关。

关键数值与推荐

  • 当前指南建议可吞咽胶囊海绵装置联合生物标志物作为内镜替代方案用于高危患者BE检测。
  • 纳入标准为有反流症状且无BE病史的成人,同时报告胶囊海绵TFF3与内镜评估结果。

临床怎么用

  • 对有反流症状且无BE病史的患者,可考虑胶囊海绵TFF3作为微创筛查选项。
  • 阴性预测值较高,有助于在低患病率人群中排除BE。
  • 吸烟或使用抑酸剂的患者特异度更高,可能减少不必要的内镜检查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Current guidelines suggest swallowable capsule-sponge devices with biomarkers can be used as alternatives to endoscopy for detecting Barrett's Esophagus (BE) in at-risk patients. We analyzed the screening performance of capsule-sponge with trefoil-factor-3 (TFF3) in patients with symptomatic acid reflux and assessed test performance across individual risk factors. METHODS: The study protocol was registered in Prospective Register of Systematic Reviews (PROSPERO) (CRD420250652091). Eligible studies reported results for both capsule-sponge-TFF3 and endoscopic assessment in adults with reflux symptoms and no history of BE. A systematic search was conducted through August 29, 2025. Two reviewers independently screened and extracted data using COllaboration + eVIDENCE (COVIDENCE). Risk of bias was assessed by QUality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). Sensitivity and specificity were estimated in SAS v9.4 using bivariate mixed models allowing estimation of likelihood ratios, diagnostic odds ratios, and predictive values; meta-regression models were estimated for individual risk factors, acid suppressant use and BE prevalence. RESULTS: We identified 6 studies involving 1,454 participants in our meta-analysis. Pooled sensitivity for BE was 0.87 (95% CI: 0.80-0.94), specificity was 0.88 (95% CI: 0.80-0.95), negative predictive value at 20% prevalence was 0.96 (95% CI: 0.95-0.98), and the diagnostic odds ratio was 47.82 (95% CI: 44.99-50.83). Smoking and acid suppressant use were associated with increased specificity. DISCUSSION: Overall, our findings show that capsule-sponge-TFF3 is an effective minimally invasive screening tool for patients at risk of BE. Increased specificity in smokers may help reduce unnecessary endoscopies in this higher-risk group.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Canto EA, Rai AK, Lostetter SJ, et al. Diagnostic Accuracy of a Capsule Sponge Trefoil Factor 3 Test for Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2026. PMID: 42669464. doi:10.14309/ajg.0000000000004190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。